InspireMD Gains MGuard Prime Approval in Brazil

April 27, 2015

InspireMD’s MGuard Prime with MicroNet technology, a stent embolic protection system, has won regulatory approval in Brazil, the Boston, Mass., devicemaker announced Monday.

The device was developed to trap and seal thrombus and raptured plaque, prevent distal embolization and maximize flow in segment elevation myocardial infarction patients, the company says.

Brazil, with a rapidly aging population, growing economy and improving healthcare system that is boosting the number of coronary stent procedures, has the largest coronary stent market in Latin America, CEO Alan Milinazzo says.

The Brazil, Russia, India, China, South Africa and South Korea coronary stents sector is projected to reach $1 billion by 2016.

The device is CE Mark-approved but is not authorized for sale in the U.S. Jason Scott